Tirzepatide (Mounjaro) Pen

Tirzepatide (Mounjaro) Pen

The Tirzepatide injection pen, marketed under Mounjaro, is a prefilled, ready-to-use delivery device designed for once-weekly subcutaneous administration in approved medical treatments.

🔬 Key Benefits (Clinical Context)

• Supports blood glucose control in type 2 diabetes
• Helps regulate appetite and food intake
• Assists with metabolic and weight-related management (approved use cases)
• Provides simple, accurate weekly dosing

⚙️ Device Overview

• Type: Prefilled injection pen
• Active ingredient: Tirzepatide
• Administration: Subcutaneous injection
• Dosing schedule: Typically once weekly (per prescription)
• Design: User-friendly, fixed-dose or titration-based system depending on strength

🧬 Mechanism of Action

Tirzepatide activates two incretin pathways:

• GIP (glucose-dependent insulinotropic polypeptide)
• GLP-1 (glucagon-like peptide-1)

This leads to:

• Improved insulin response
• Reduced glucagon secretion
• Slower gastric emptying
• Increased satiety and reduced appetite